SE417972B - Forfarande for framstellning av antibiotiska derivat av kanamycin a eller b - Google Patents

Forfarande for framstellning av antibiotiska derivat av kanamycin a eller b

Info

Publication number
SE417972B
SE417972B SE7402334A SE7402334A SE417972B SE 417972 B SE417972 B SE 417972B SE 7402334 A SE7402334 A SE 7402334A SE 7402334 A SE7402334 A SE 7402334A SE 417972 B SE417972 B SE 417972B
Authority
SE
Sweden
Prior art keywords
canamycin
procedure
preparation
antibiotic derivatives
antibiotic
Prior art date
Application number
SE7402334A
Other languages
English (en)
Swedish (sv)
Inventor
T Naito
S Nakagawa
Y Abe
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US335211A external-priority patent/US3904597A/en
Priority claimed from US335210A external-priority patent/US3886139A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE417972B publication Critical patent/SE417972B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7402334A 1973-02-23 1974-02-21 Forfarande for framstellning av antibiotiska derivat av kanamycin a eller b SE417972B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US335211A US3904597A (en) 1973-02-23 1973-02-23 Antibiotic derivatives
US335210A US3886139A (en) 1973-02-23 1973-02-23 Derivatives of kanamycin

Publications (1)

Publication Number Publication Date
SE417972B true SE417972B (sv) 1981-04-27

Family

ID=26989599

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7402334A SE417972B (sv) 1973-02-23 1974-02-21 Forfarande for framstellning av antibiotiska derivat av kanamycin a eller b

Country Status (9)

Country Link
JP (1) JPS553360B2 (de)
CA (1) CA1046513A (de)
CH (1) CH599243A5 (de)
DE (1) DE2408666C3 (de)
DK (1) DK140259B (de)
FR (1) FR2218879B2 (de)
GB (1) GB1467401A (de)
NL (1) NL7402456A (de)
SE (1) SE417972B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512038B2 (de) * 1973-05-15 1980-03-29
EP0000473B1 (en) * 1977-06-24 1981-03-11 Scherico Ltd. Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives
US9981896B2 (en) 2016-07-01 2018-05-29 Res Usa, Llc Conversion of methane to dimethyl ether
US9938217B2 (en) 2016-07-01 2018-04-10 Res Usa, Llc Fluidized bed membrane reactor
WO2018004993A1 (en) 2016-07-01 2018-01-04 Res Usa, Llc Reduction of greenhouse gas emission

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205516A1 (es) * 1972-03-08 1976-05-14 Bristol Myers Co Proceso para la preparacion de derivados de tobramicina

Also Published As

Publication number Publication date
DK140259C (de) 1979-12-10
NL7402456A (de) 1974-08-27
DE2408666B2 (de) 1978-02-16
FR2218879A2 (de) 1974-09-20
CH599243A5 (de) 1978-05-31
DK140259B (da) 1979-07-16
AU6587574A (en) 1975-08-21
JPS553360B2 (de) 1980-01-24
CA1046513A (en) 1979-01-16
DE2408666C3 (de) 1978-10-19
FR2218879B2 (de) 1978-05-26
JPS504043A (de) 1975-01-16
GB1467401A (en) 1977-03-16
DE2408666A1 (de) 1974-09-12

Similar Documents

Publication Publication Date Title
SE419981B (sv) Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat
SE445923B (sv) Forfarande for framstellning av glukosaminderivat
SE420201B (sv) Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE397972B (sv) Forfarande for framstellning av nya derivat av dibenso/a,d/cyklohepten-5-on
SE415834B (sv) Analogiforfarande for framstellning av pyrazolderivat
SE420098B (sv) Forfarande for framstellning av linkomycinderivat
SE435513B (sv) Forfarande for framstellning av derivat av kanamycin a eller b
SE421212B (sv) Forfarande for framstellning av nya derivat av daunorubicin
SE417972B (sv) Forfarande for framstellning av antibiotiska derivat av kanamycin a eller b
SE420716B (sv) Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat
SE382980B (sv) Forfarande for framstellning av nya derivat av hexahydrofenantridin
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
SE421129B (sv) Forfarande for framstellning av poly-n-alkyl-iminoalaner
SE7507648L (sv) Forfarande for framstellning av basiskt substituerade derivat av 4-hydroxi-bensimidazol
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE417825B (sv) Analogiforfarande for framstellning av derivat av antibiotikum xk-62-2
NO139864C (no) B fremgangsmaate til fremstilling av antibiotikum fortimicin
SE415100B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE404367B (sv) Forfarande for framstellning av derivat av homofolsyra
SE417966B (sv) Forfarande for framstellning av pyrimidinoaminometyl-ergolinderivat
SE409325B (sv) Forfarande for framstellning av kinazolinonderivat
ZA743764B (en) Process for the preparation of antibiotic derivatives
SE412910B (sv) Forfarande for framstellning av derivat av 1,3-bensodioxol
SE7709240L (sv) Forfarande for framstellning av nitroindandionderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7402334-2

Effective date: 19880125

Format of ref document f/p: F